Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 41 | 2021 | 1509 | 5.240 |
Why?
|
Blood Vessel Prosthesis Implantation | 31 | 2023 | 1460 | 4.350 |
Why?
|
Aortic Aneurysm, Abdominal | 18 | 2022 | 1252 | 3.560 |
Why?
|
Lower Extremity | 24 | 2017 | 1214 | 2.440 |
Why?
|
Ischemia | 25 | 2024 | 1900 | 2.390 |
Why?
|
Peripheral Arterial Disease | 24 | 2024 | 1299 | 2.350 |
Why?
|
Arterial Occlusive Diseases | 13 | 2019 | 751 | 2.280 |
Why?
|
Limb Salvage | 20 | 2024 | 489 | 2.130 |
Why?
|
Endovascular Procedures | 19 | 2024 | 2258 | 2.130 |
Why?
|
Popliteal Artery | 12 | 2022 | 313 | 1.930 |
Why?
|
Vascular Patency | 34 | 2023 | 916 | 1.830 |
Why?
|
Blood Vessel Prosthesis | 14 | 2023 | 959 | 1.810 |
Why?
|
Graft Occlusion, Vascular | 16 | 2024 | 538 | 1.620 |
Why?
|
Femoral Artery | 14 | 2022 | 829 | 1.610 |
Why?
|
Stents | 14 | 2020 | 3204 | 1.600 |
Why?
|
Endarterectomy, Carotid | 8 | 2018 | 558 | 1.520 |
Why?
|
Angioplasty, Balloon | 4 | 2022 | 592 | 1.200 |
Why?
|
Iliac Artery | 3 | 2019 | 344 | 1.200 |
Why?
|
Saphenous Vein | 10 | 2024 | 519 | 1.180 |
Why?
|
Arteriovenous Shunt, Surgical | 9 | 2023 | 291 | 1.080 |
Why?
|
Carotid Stenosis | 7 | 2018 | 864 | 1.010 |
Why?
|
Leg | 9 | 2013 | 1089 | 0.980 |
Why?
|
Veins | 15 | 2017 | 767 | 0.930 |
Why?
|
Endoleak | 4 | 2017 | 111 | 0.900 |
Why?
|
Peripheral Vascular Diseases | 9 | 2011 | 489 | 0.850 |
Why?
|
Aortic Diseases | 5 | 2018 | 742 | 0.850 |
Why?
|
Intermittent Claudication | 6 | 2016 | 305 | 0.820 |
Why?
|
Lithotripsy | 1 | 2023 | 141 | 0.810 |
Why?
|
Treatment Outcome | 75 | 2023 | 65408 | 0.760 |
Why?
|
Time Factors | 53 | 2023 | 40271 | 0.750 |
Why?
|
Reoperation | 20 | 2023 | 4342 | 0.750 |
Why?
|
Subclavian Artery | 2 | 2019 | 133 | 0.750 |
Why?
|
Trabeculectomy | 3 | 2017 | 174 | 0.660 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.630 |
Why?
|
Device Removal | 3 | 2021 | 641 | 0.620 |
Why?
|
Carotid Body Tumor | 1 | 2018 | 34 | 0.610 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 879 | 0.590 |
Why?
|
Gonioscopy | 2 | 2017 | 157 | 0.570 |
Why?
|
Vascular Fistula | 2 | 2020 | 50 | 0.540 |
Why?
|
Dissection | 1 | 2018 | 299 | 0.540 |
Why?
|
Patient Readmission | 5 | 2014 | 3308 | 0.530 |
Why?
|
Intestinal Fistula | 2 | 2020 | 144 | 0.520 |
Why?
|
Exfoliation Syndrome | 1 | 2017 | 113 | 0.520 |
Why?
|
Postoperative Complications | 22 | 2022 | 15879 | 0.510 |
Why?
|
Sclera | 1 | 2017 | 190 | 0.510 |
Why?
|
Intraoperative Care | 1 | 2019 | 772 | 0.500 |
Why?
|
Inguinal Canal | 3 | 2005 | 71 | 0.500 |
Why?
|
Embolization, Therapeutic | 2 | 2023 | 1435 | 0.490 |
Why?
|
Models, Economic | 4 | 2016 | 717 | 0.490 |
Why?
|
Aortography | 6 | 2018 | 422 | 0.490 |
Why?
|
Aged | 89 | 2024 | 171514 | 0.480 |
Why?
|
Laser Therapy | 3 | 2017 | 1107 | 0.460 |
Why?
|
Renal Dialysis | 8 | 2023 | 1802 | 0.450 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2015 | 709 | 0.450 |
Why?
|
Retrospective Studies | 54 | 2024 | 81835 | 0.440 |
Why?
|
Deglutition Disorders | 1 | 2019 | 637 | 0.440 |
Why?
|
Foot Ulcer | 1 | 2014 | 62 | 0.440 |
Why?
|
Health Care Costs | 5 | 2016 | 3266 | 0.430 |
Why?
|
Emergencies | 1 | 2019 | 1222 | 0.420 |
Why?
|
Aorta | 3 | 2021 | 2046 | 0.420 |
Why?
|
Risk Factors | 45 | 2024 | 74915 | 0.410 |
Why?
|
Kaplan-Meier Estimate | 14 | 2017 | 6537 | 0.410 |
Why?
|
Radial Artery | 4 | 2022 | 188 | 0.400 |
Why?
|
Risk Assessment | 28 | 2023 | 24310 | 0.400 |
Why?
|
Length of Stay | 8 | 2021 | 6521 | 0.400 |
Why?
|
Iliac Aneurysm | 1 | 2012 | 37 | 0.390 |
Why?
|
Male | 99 | 2024 | 364761 | 0.390 |
Why?
|
Aged, 80 and over | 38 | 2024 | 59679 | 0.380 |
Why?
|
Hospital Costs | 2 | 2014 | 959 | 0.360 |
Why?
|
Prosthesis-Related Infections | 3 | 2022 | 491 | 0.360 |
Why?
|
Humans | 130 | 2024 | 768369 | 0.350 |
Why?
|
Multivariate Analysis | 18 | 2017 | 12096 | 0.350 |
Why?
|
Glaucoma, Open-Angle | 1 | 2017 | 742 | 0.350 |
Why?
|
Visual Acuity | 4 | 2017 | 2714 | 0.350 |
Why?
|
Specialties, Surgical | 1 | 2015 | 393 | 0.340 |
Why?
|
Middle Aged | 67 | 2024 | 223406 | 0.340 |
Why?
|
Foot | 1 | 2014 | 577 | 0.340 |
Why?
|
Female | 92 | 2024 | 396926 | 0.330 |
Why?
|
Angioplasty | 3 | 2021 | 357 | 0.330 |
Why?
|
Aneurysm | 2 | 2010 | 338 | 0.330 |
Why?
|
Workload | 2 | 2020 | 852 | 0.330 |
Why?
|
Ultrasonography, Doppler, Duplex | 8 | 2024 | 198 | 0.320 |
Why?
|
Education, Medical, Graduate | 2 | 2014 | 2411 | 0.320 |
Why?
|
Patient Selection | 10 | 2018 | 4266 | 0.320 |
Why?
|
Venous Thrombosis | 2 | 2009 | 1317 | 0.310 |
Why?
|
Vision Disorders | 1 | 2016 | 1092 | 0.310 |
Why?
|
Proportional Hazards Models | 15 | 2017 | 12561 | 0.300 |
Why?
|
Markov Chains | 5 | 2016 | 977 | 0.300 |
Why?
|
Chi-Square Distribution | 9 | 2017 | 3438 | 0.300 |
Why?
|
Prosthesis Design | 7 | 2023 | 2126 | 0.300 |
Why?
|
Polytetrafluoroethylene | 2 | 2023 | 245 | 0.300 |
Why?
|
Wound Healing | 10 | 2017 | 2819 | 0.280 |
Why?
|
Registries | 11 | 2021 | 8372 | 0.280 |
Why?
|
Laser Coagulation | 4 | 2012 | 333 | 0.270 |
Why?
|
Referral and Consultation | 1 | 2019 | 3629 | 0.270 |
Why?
|
Kidney Failure, Chronic | 2 | 2021 | 2489 | 0.260 |
Why?
|
Retreatment | 4 | 2017 | 601 | 0.260 |
Why?
|
Vascular Grafting | 4 | 2024 | 163 | 0.260 |
Why?
|
Renal Veins | 1 | 2006 | 103 | 0.260 |
Why?
|
Arteriovenous Fistula | 2 | 2022 | 321 | 0.250 |
Why?
|
Databases, Factual | 6 | 2023 | 8081 | 0.250 |
Why?
|
Arteries | 3 | 2013 | 1126 | 0.250 |
Why?
|
Robotics | 1 | 2012 | 826 | 0.240 |
Why?
|
Prosthesis Failure | 2 | 2018 | 1208 | 0.240 |
Why?
|
Congresses as Topic | 1 | 2009 | 810 | 0.230 |
Why?
|
Iliac Vein | 1 | 2004 | 70 | 0.230 |
Why?
|
Aneurysm, Ruptured | 1 | 2009 | 469 | 0.230 |
Why?
|
Hematoma | 3 | 2017 | 768 | 0.230 |
Why?
|
Renal Insufficiency | 2 | 2013 | 809 | 0.230 |
Why?
|
Surgery, Computer-Assisted | 1 | 2012 | 1005 | 0.220 |
Why?
|
Surgical Wound Infection | 5 | 2017 | 1544 | 0.220 |
Why?
|
Viscera | 1 | 2004 | 138 | 0.220 |
Why?
|
Intraocular Pressure | 3 | 2017 | 1304 | 0.220 |
Why?
|
Follow-Up Studies | 21 | 2022 | 39429 | 0.210 |
Why?
|
American Heart Association | 4 | 2011 | 1049 | 0.210 |
Why?
|
Odds Ratio | 11 | 2017 | 9687 | 0.210 |
Why?
|
Visually Impaired Persons | 2 | 2016 | 79 | 0.210 |
Why?
|
Vena Cava, Inferior | 1 | 2006 | 463 | 0.210 |
Why?
|
Critical Illness | 7 | 2016 | 2754 | 0.210 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2179 | 0.210 |
Why?
|
Cost-Benefit Analysis | 7 | 2016 | 5532 | 0.210 |
Why?
|
Atherectomy | 1 | 2022 | 42 | 0.210 |
Why?
|
Recovery of Function | 7 | 2019 | 2994 | 0.200 |
Why?
|
Groin | 3 | 2013 | 107 | 0.200 |
Why?
|
Advisory Committees | 3 | 2011 | 797 | 0.200 |
Why?
|
Clinical Competence | 3 | 2020 | 4841 | 0.200 |
Why?
|
Carotid Arteries | 3 | 2023 | 943 | 0.200 |
Why?
|
Retinal Diseases | 4 | 2012 | 711 | 0.200 |
Why?
|
United States | 26 | 2024 | 73120 | 0.190 |
Why?
|
Cognition Disorders | 1 | 2016 | 3984 | 0.190 |
Why?
|
Age Factors | 7 | 2019 | 18477 | 0.190 |
Why?
|
Boston | 11 | 2021 | 9359 | 0.190 |
Why?
|
Wrist | 2 | 2021 | 232 | 0.180 |
Why?
|
Electroporation | 2 | 2013 | 236 | 0.180 |
Why?
|
Forearm | 1 | 2023 | 428 | 0.180 |
Why?
|
Glaucoma, Angle-Closure | 2 | 2015 | 192 | 0.180 |
Why?
|
Amblyopia | 1 | 2022 | 152 | 0.180 |
Why?
|
Brachial Artery | 2 | 2023 | 374 | 0.170 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2013 | 263 | 0.170 |
Why?
|
Video Games | 1 | 2022 | 201 | 0.170 |
Why?
|
Retina | 6 | 2013 | 2663 | 0.170 |
Why?
|
Comorbidity | 10 | 2019 | 10601 | 0.170 |
Why?
|
Laparoscopy | 1 | 2012 | 2056 | 0.170 |
Why?
|
Thrombolytic Therapy | 1 | 2009 | 2058 | 0.170 |
Why?
|
Prospective Studies | 23 | 2022 | 54913 | 0.170 |
Why?
|
Severity of Illness Index | 11 | 2019 | 15965 | 0.170 |
Why?
|
Transplantation, Autologous | 8 | 2009 | 2126 | 0.170 |
Why?
|
Angiography | 4 | 2016 | 1597 | 0.160 |
Why?
|
Ultrasonography, Interventional | 1 | 2007 | 1520 | 0.160 |
Why?
|
Eye Injuries | 2 | 2012 | 228 | 0.150 |
Why?
|
Trabecular Meshwork | 2 | 2017 | 101 | 0.150 |
Why?
|
Deglutition | 1 | 2019 | 208 | 0.150 |
Why?
|
Cognition | 1 | 2016 | 7062 | 0.150 |
Why?
|
Certification | 2 | 2014 | 419 | 0.150 |
Why?
|
Databases as Topic | 2 | 2011 | 475 | 0.150 |
Why?
|
Health Status Disparities | 1 | 2009 | 1876 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 2 | 2016 | 335 | 0.140 |
Why?
|
Ocular Hypotension | 1 | 2017 | 23 | 0.140 |
Why?
|
Israel | 2 | 2017 | 726 | 0.140 |
Why?
|
Seroma | 1 | 2017 | 74 | 0.140 |
Why?
|
Aging | 1 | 2016 | 8762 | 0.140 |
Why?
|
History, 20th Century | 2 | 2015 | 2772 | 0.130 |
Why?
|
Tonometry, Ocular | 1 | 2017 | 238 | 0.130 |
Why?
|
Renal Artery | 2 | 2010 | 353 | 0.130 |
Why?
|
Polymers | 1 | 2023 | 1631 | 0.130 |
Why?
|
Neuroprotective Agents | 3 | 2012 | 960 | 0.130 |
Why?
|
Anastomosis, Surgical | 2 | 2012 | 993 | 0.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 704 | 0.120 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2016 | 153 | 0.120 |
Why?
|
Cloprostenol | 1 | 2015 | 21 | 0.120 |
Why?
|
Aorta, Abdominal | 2 | 2017 | 627 | 0.120 |
Why?
|
Cause of Death | 2 | 2012 | 3727 | 0.120 |
Why?
|
Health Resources | 3 | 2013 | 950 | 0.120 |
Why?
|
Aneurysm, False | 2 | 2017 | 264 | 0.120 |
Why?
|
Frail Elderly | 1 | 2020 | 774 | 0.120 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 641 | 0.120 |
Why?
|
Intelligence Tests | 1 | 2016 | 504 | 0.120 |
Why?
|
Logistic Models | 6 | 2017 | 13323 | 0.120 |
Why?
|
Refraction, Ocular | 1 | 2016 | 186 | 0.120 |
Why?
|
Eyeglasses | 1 | 2016 | 138 | 0.120 |
Why?
|
History, 18th Century | 1 | 2015 | 207 | 0.120 |
Why?
|
Forecasting | 2 | 2014 | 2950 | 0.110 |
Why?
|
Informed Consent | 1 | 2020 | 1012 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 937 | 0.110 |
Why?
|
Decision Support Techniques | 3 | 2012 | 2010 | 0.110 |
Why?
|
Stroke | 5 | 2014 | 9790 | 0.110 |
Why?
|
Alginates | 1 | 2014 | 250 | 0.100 |
Why?
|
Internship and Residency | 2 | 2014 | 5952 | 0.100 |
Why?
|
Massachusetts | 3 | 2019 | 8905 | 0.100 |
Why?
|
Aorta, Thoracic | 2 | 2013 | 1107 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 4049 | 0.100 |
Why?
|
Polyesters | 1 | 2014 | 375 | 0.100 |
Why?
|
Bandages | 1 | 2014 | 273 | 0.100 |
Why?
|
Propensity Score | 4 | 2015 | 1970 | 0.100 |
Why?
|
History, 19th Century | 1 | 2015 | 716 | 0.100 |
Why?
|
Diabetic Foot | 1 | 2016 | 383 | 0.100 |
Why?
|
Extremities | 2 | 2007 | 870 | 0.100 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1514 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 248 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 683 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 319 | 0.100 |
Why?
|
Polyethylenes | 1 | 2014 | 290 | 0.100 |
Why?
|
beta Carotene | 1 | 2013 | 523 | 0.100 |
Why?
|
Constriction, Pathologic | 2 | 2016 | 1103 | 0.100 |
Why?
|
Tibial Arteries | 3 | 2007 | 60 | 0.100 |
Why?
|
Foundations | 1 | 2011 | 96 | 0.090 |
Why?
|
Life Tables | 2 | 2012 | 368 | 0.090 |
Why?
|
Regional Blood Flow | 3 | 2017 | 1503 | 0.090 |
Why?
|
Chronic Disease | 4 | 2015 | 9379 | 0.090 |
Why?
|
Graft Rejection | 4 | 2012 | 4505 | 0.090 |
Why?
|
Cohort Studies | 8 | 2023 | 41782 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 2 | 2009 | 1434 | 0.090 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 402 | 0.090 |
Why?
|
Economic Competition | 1 | 2013 | 223 | 0.090 |
Why?
|
Graft Survival | 4 | 2012 | 3890 | 0.090 |
Why?
|
Nursing | 1 | 2010 | 35 | 0.090 |
Why?
|
Capillary Permeability | 1 | 2014 | 773 | 0.090 |
Why?
|
Arteriosclerosis | 2 | 2008 | 1056 | 0.090 |
Why?
|
Adult | 20 | 2019 | 223528 | 0.090 |
Why?
|
Survival Rate | 6 | 2020 | 12875 | 0.090 |
Why?
|
Blood Flow Velocity | 4 | 2022 | 1377 | 0.090 |
Why?
|
Ophthalmic Solutions | 2 | 2009 | 315 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 20763 | 0.090 |
Why?
|
Uveal Neoplasms | 1 | 2013 | 344 | 0.090 |
Why?
|
Disease Progression | 3 | 2017 | 13643 | 0.090 |
Why?
|
Patient Discharge | 2 | 2014 | 3471 | 0.090 |
Why?
|
Microvessels | 1 | 2014 | 586 | 0.090 |
Why?
|
Sodium Chloride | 1 | 2012 | 585 | 0.090 |
Why?
|
Cardiology | 2 | 2011 | 1701 | 0.090 |
Why?
|
Treatment Failure | 3 | 2014 | 2655 | 0.080 |
Why?
|
C-Reactive Protein | 3 | 2012 | 3854 | 0.080 |
Why?
|
Retinitis Pigmentosa | 1 | 2013 | 397 | 0.080 |
Why?
|
Societies, Medical | 3 | 2010 | 3954 | 0.080 |
Why?
|
Probability | 2 | 2005 | 2483 | 0.080 |
Why?
|
Iridectomy | 1 | 2009 | 48 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2014 | 806 | 0.080 |
Why?
|
Constriction | 1 | 2009 | 168 | 0.080 |
Why?
|
Brachytherapy | 1 | 2016 | 1227 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 26348 | 0.080 |
Why?
|
Endoscopy, Digestive System | 1 | 2011 | 354 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 2 | 2012 | 1734 | 0.080 |
Why?
|
Fibrinogen | 1 | 2012 | 893 | 0.080 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5887 | 0.080 |
Why?
|
Research Report | 1 | 2011 | 369 | 0.080 |
Why?
|
Hospitals | 2 | 2013 | 3906 | 0.080 |
Why?
|
Survival Analysis | 5 | 2013 | 10127 | 0.070 |
Why?
|
Drug Contamination | 1 | 2009 | 152 | 0.070 |
Why?
|
Curriculum | 2 | 2014 | 3778 | 0.070 |
Why?
|
Ultrasonography, Doppler | 2 | 2007 | 463 | 0.070 |
Why?
|
Thrombosis | 1 | 2022 | 2954 | 0.070 |
Why?
|
Blindness | 1 | 2012 | 588 | 0.070 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2009 | 235 | 0.070 |
Why?
|
History, 21st Century | 1 | 2014 | 1575 | 0.070 |
Why?
|
Women | 1 | 2009 | 225 | 0.070 |
Why?
|
Delirium | 1 | 2019 | 1694 | 0.070 |
Why?
|
Mesenteric Artery, Superior | 2 | 2005 | 96 | 0.070 |
Why?
|
Adult Stem Cells | 1 | 2009 | 222 | 0.070 |
Why?
|
Cell Communication | 1 | 2014 | 1662 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5371 | 0.070 |
Why?
|
Equipment Design | 1 | 2015 | 3530 | 0.070 |
Why?
|
Photoperiod | 1 | 2007 | 141 | 0.070 |
Why?
|
Recurrence | 3 | 2016 | 8510 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2861 | 0.070 |
Why?
|
Intraoperative Period | 1 | 2007 | 513 | 0.070 |
Why?
|
Diagnostic Imaging | 3 | 2010 | 3543 | 0.060 |
Why?
|
Lasers | 1 | 2010 | 952 | 0.060 |
Why?
|
E2F Transcription Factors | 1 | 2006 | 270 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2017 | 10358 | 0.060 |
Why?
|
Program Evaluation | 2 | 2015 | 2508 | 0.060 |
Why?
|
Anesthesia | 1 | 2016 | 1596 | 0.060 |
Why?
|
Knee Joint | 1 | 2013 | 1683 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1134 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1638 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2008 | 544 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2724 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2194 | 0.060 |
Why?
|
Myopia | 1 | 2007 | 252 | 0.060 |
Why?
|
Preoperative Care | 2 | 2024 | 2257 | 0.060 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2005 | 93 | 0.060 |
Why?
|
Quality Indicators, Health Care | 2 | 2013 | 1813 | 0.060 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 177 | 0.060 |
Why?
|
Aneurysm, Infected | 1 | 2005 | 82 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2643 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2011 | 1126 | 0.060 |
Why?
|
Postoperative Hemorrhage | 1 | 2007 | 420 | 0.060 |
Why?
|
Computer Simulation | 2 | 2016 | 6278 | 0.060 |
Why?
|
Thrombectomy | 1 | 2009 | 706 | 0.060 |
Why?
|
Incidence | 5 | 2016 | 21552 | 0.060 |
Why?
|
Comparative Effectiveness Research | 2 | 2023 | 712 | 0.050 |
Why?
|
Internal Medicine | 1 | 2010 | 1056 | 0.050 |
Why?
|
Parturition | 1 | 2007 | 453 | 0.050 |
Why?
|
General Surgery | 1 | 2015 | 1714 | 0.050 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2009 | 844 | 0.050 |
Why?
|
Ankle Brachial Index | 2 | 2016 | 163 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2014 | 2753 | 0.050 |
Why?
|
Vena Cava Filters | 1 | 2006 | 270 | 0.050 |
Why?
|
Quinoxalines | 1 | 2005 | 297 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7133 | 0.050 |
Why?
|
Radiography | 2 | 2004 | 6995 | 0.050 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2005 | 252 | 0.050 |
Why?
|
Sensory Deprivation | 1 | 2022 | 109 | 0.050 |
Why?
|
Mesenteric Arteries | 1 | 2002 | 178 | 0.050 |
Why?
|
Survivors | 1 | 2013 | 2379 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 1369 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3407 | 0.050 |
Why?
|
Endarterectomy | 1 | 2002 | 196 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4077 | 0.050 |
Why?
|
Choroidal Neovascularization | 1 | 2005 | 364 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2431 | 0.050 |
Why?
|
Embolism | 1 | 2005 | 401 | 0.050 |
Why?
|
Seasons | 1 | 2007 | 1526 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 3253 | 0.050 |
Why?
|
Aortic Rupture | 1 | 2004 | 322 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2016 | 15459 | 0.050 |
Why?
|
Vision, Binocular | 1 | 2022 | 225 | 0.050 |
Why?
|
Oligonucleotides | 3 | 2008 | 564 | 0.040 |
Why?
|
Health Status | 1 | 2014 | 4096 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6856 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2013 | 7863 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3858 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2017 | 1727 | 0.040 |
Why?
|
Lasers, Gas | 2 | 2012 | 101 | 0.040 |
Why?
|
Quality of Life | 4 | 2016 | 13497 | 0.040 |
Why?
|
Ligation | 1 | 2021 | 447 | 0.040 |
Why?
|
Inflammation Mediators | 3 | 2014 | 1892 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3922 | 0.040 |
Why?
|
Intravitreal Injections | 2 | 2012 | 401 | 0.040 |
Why?
|
Linear Models | 3 | 2014 | 5880 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 13030 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2005 | 864 | 0.040 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 8051 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2023 | 592 | 0.040 |
Why?
|
Administration, Topical | 2 | 2014 | 707 | 0.040 |
Why?
|
Electroretinography | 2 | 2013 | 524 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7245 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4417 | 0.040 |
Why?
|
Heart Failure | 3 | 2014 | 11859 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6657 | 0.040 |
Why?
|
Prevalence | 4 | 2019 | 15879 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2004 | 1494 | 0.040 |
Why?
|
Cattle | 1 | 2023 | 3830 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2013 | 12450 | 0.030 |
Why?
|
Radiology | 1 | 2010 | 2118 | 0.030 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 34 | 0.030 |
Why?
|
Medical Errors | 1 | 2005 | 1263 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3431 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 520 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2017 | 216 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2010 | 4340 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 406 | 0.030 |
Why?
|
Ultrasonography, Doppler, Pulsed | 1 | 2014 | 19 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2006 | 1292 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2004 | 1683 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3412 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2006 | 2145 | 0.030 |
Why?
|
Melanoma | 1 | 2013 | 5740 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.030 |
Why?
|
Sex Factors | 3 | 2017 | 10647 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10863 | 0.030 |
Why?
|
Young Adult | 4 | 2014 | 60038 | 0.030 |
Why?
|
North America | 2 | 2007 | 1292 | 0.030 |
Why?
|
Chlorophyta | 1 | 2013 | 15 | 0.030 |
Why?
|
Rats | 4 | 2012 | 23839 | 0.030 |
Why?
|
Eye Enucleation | 1 | 2013 | 128 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2010 | 7449 | 0.030 |
Why?
|
Powders | 1 | 2013 | 79 | 0.030 |
Why?
|
Foreign-Body Migration | 1 | 2015 | 220 | 0.030 |
Why?
|
Hemodynamics | 2 | 2014 | 4202 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1408 | 0.030 |
Why?
|
Texas | 1 | 2014 | 405 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 417 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 36840 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 952 | 0.030 |
Why?
|
Edema | 1 | 2017 | 766 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 16023 | 0.030 |
Why?
|
Elasticity | 2 | 2006 | 658 | 0.030 |
Why?
|
Guided Tissue Regeneration | 1 | 2013 | 88 | 0.030 |
Why?
|
Oxygen | 1 | 2005 | 4269 | 0.030 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2007 | 2291 | 0.030 |
Why?
|
Administration, Oral | 2 | 2013 | 4040 | 0.030 |
Why?
|
Dark Adaptation | 1 | 2013 | 224 | 0.030 |
Why?
|
Blood Donors | 1 | 2014 | 345 | 0.030 |
Why?
|
Hindlimb | 1 | 2014 | 516 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 469 | 0.020 |
Why?
|
Anticoagulants | 1 | 2007 | 4835 | 0.020 |
Why?
|
Cardiovascular Agents | 2 | 2007 | 849 | 0.020 |
Why?
|
Cost Savings | 1 | 2016 | 917 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2012 | 2226 | 0.020 |
Why?
|
Ablation Techniques | 1 | 2013 | 249 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2014 | 1343 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2013 | 5308 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2339 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 1438 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2010 | 317 | 0.020 |
Why?
|
New England | 1 | 2013 | 1056 | 0.020 |
Why?
|
Hospital Bed Capacity | 1 | 2010 | 206 | 0.020 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2009 | 34 | 0.020 |
Why?
|
Eye | 1 | 2013 | 715 | 0.020 |
Why?
|
Vascular Diseases | 2 | 2010 | 1162 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2009 | 329 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2014 | 18390 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1379 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4984 | 0.020 |
Why?
|
Iris | 1 | 2009 | 231 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 14157 | 0.020 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 730 | 0.020 |
Why?
|
Drug Compounding | 1 | 2009 | 243 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2016 | 1974 | 0.020 |
Why?
|
Prognosis | 3 | 2016 | 30031 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3635 | 0.020 |
Why?
|
Ocular Hypertension | 1 | 2009 | 211 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2399 | 0.020 |
Why?
|
Electromagnetic Fields | 1 | 2009 | 290 | 0.020 |
Why?
|
Animals | 6 | 2023 | 169424 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2010 | 2768 | 0.020 |
Why?
|
Light | 1 | 2013 | 1357 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2103 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1888 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 2286 | 0.020 |
Why?
|
Hospitalization | 1 | 2006 | 10845 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 19035 | 0.020 |
Why?
|
Visual Fields | 1 | 2013 | 1067 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2881 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3615 | 0.020 |
Why?
|
Cataract | 1 | 2012 | 837 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2048 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16712 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2007 | 882 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2028 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 2006 | 2087 | 0.020 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2006 | 203 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 649 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 2488 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2731 | 0.010 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 1086 | 0.010 |
Why?
|
Macular Degeneration | 1 | 2012 | 1016 | 0.010 |
Why?
|
Benchmarking | 1 | 2010 | 1058 | 0.010 |
Why?
|
Adolescent | 4 | 2014 | 89163 | 0.010 |
Why?
|
Exercise Therapy | 1 | 2010 | 941 | 0.010 |
Why?
|
Minority Groups | 1 | 2010 | 1215 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2742 | 0.010 |
Why?
|
Hand | 1 | 2008 | 907 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2014 | 1547 | 0.010 |
Why?
|
Research Design | 2 | 2009 | 6217 | 0.010 |
Why?
|
Temperature | 1 | 2009 | 2237 | 0.010 |
Why?
|
Time | 1 | 2004 | 546 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2004 | 241 | 0.010 |
Why?
|
Diabetic Retinopathy | 1 | 2012 | 1299 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1244 | 0.010 |
Why?
|
Glaucoma | 1 | 2012 | 1192 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1833 | 0.010 |
Why?
|
Oximetry | 1 | 2005 | 462 | 0.010 |
Why?
|
Cost of Illness | 1 | 2011 | 1960 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5803 | 0.010 |
Why?
|
Creatinine | 1 | 2007 | 1915 | 0.010 |
Why?
|
Medicare | 1 | 2019 | 6880 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5337 | 0.010 |
Why?
|
Lipids | 1 | 2012 | 3346 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2119 | 0.010 |
Why?
|
Endocarditis | 1 | 2005 | 355 | 0.010 |
Why?
|
Catheterization | 1 | 2006 | 1431 | 0.010 |
Why?
|
Child | 2 | 2022 | 80856 | 0.010 |
Why?
|
Surgical Instruments | 1 | 2002 | 386 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5797 | 0.010 |
Why?
|
Genetic Testing | 1 | 2012 | 3586 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2010 | 4526 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4941 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3708 | 0.010 |
Why?
|
Insurance, Health | 1 | 2010 | 2513 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20232 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2362 | 0.010 |
Why?
|
Medicaid | 1 | 2010 | 2843 | 0.010 |
Why?
|
Escherichia coli | 1 | 2009 | 4220 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2010 | 2958 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 3941 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14766 | 0.010 |
Why?
|
Intestines | 1 | 2005 | 1912 | 0.010 |
Why?
|
Stroke Volume | 1 | 2009 | 5620 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8537 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2002 | 1322 | 0.010 |
Why?
|
Ultrasonography | 1 | 2007 | 5994 | 0.010 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2005 | 1569 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8559 | 0.010 |
Why?
|
Pilot Projects | 1 | 2005 | 8730 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 22286 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23639 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18047 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36496 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42620 | 0.000 |
Why?
|
Mice | 1 | 2014 | 82051 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 15638 | 0.000 |
Why?
|